Real-world outcomes of patients (pts) with malignant solid tumors treated with immune checkpoint inhibitors (ICI) in relation to smoking status: The SAKK 80/19 SMOKER study

被引：0
|
作者：
El Saadany, Tamer
Petrausch, Ulf
Mora, Alfonso Rojas
Winder, Thomas
Renner, Christoph
Benda, Magdalena
Reimann, Patrick
Froesch, Patrizia
Jakob, Andreas
Daza, Adriana Clavijo
Mueller, Gisela
Von Moos, Roger Anton Fredy
Mark, Michael Thomas
机构：
[1] Kantonsspital Graubuenden, Div Hematol Oncol, Chur, Switzerland
[2] Hirslanden Zurich, Div Hematol Oncol, Zurich, Switzerland
[3] Swiss Grp Clin Canc Res SAKK, Competence Ctr, Bern, Switzerland
[4] Landeskrankenhaus Feldkirch, Internal Med 2, Feldkirch, Austria
[5] Swiss Tumor Inst, Zurich, Switzerland
[6] Hosp Feldkirch, Div Hematol Oncol, Feldkirch, Austria
[7] Hosp Feldkirch, Div Hematol Oncol, Dept Internal Med 2, Feldkirch, Austria
[8] Ente Osped Cantonale EOC, Oncol Inst Southern Switzerland IOSI, Bellinzona, Switzerland
[9] Tumor Zentrum Aarau, Aarau, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6619
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Patient-reported outcomes in patients with metastatic bone disease from solid tumors treated with bone-targeted agents: a real-world study (SAKK 95/16)
    Ribi, K.
    Thurlimann, B.
    Schar, C.
    Dietrich, D.
    Cathomas, R.
    Zurrer-Hardi, U.
    von Briel, T.
    Anchisi, S.
    Bohanes, P.
    Blum, V.
    von Burg, P.
    Mannhart, M.
    Caspar, C. B.
    von Moos, R.
    Mark, M.
    SWISS MEDICAL WEEKLY, 2020, : 27S - 28S
  • [42] Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
    Hanna, Glenn J.
    Ruiz, Emily S.
    LeBoeuf, Nicole R.
    Thakuria, Manisha
    Schmults, Chrysalyne D.
    Decaprio, James A.
    Silk, Ann W.
    BRITISH JOURNAL OF CANCER, 2020, 123 (10) : 1535 - 1542
  • [43] Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
    Glenn J. Hanna
    Emily S. Ruiz
    Nicole R. LeBoeuf
    Manisha Thakuria
    Chrysalyne D. Schmults
    James A. Decaprio
    Ann W. Silk
    British Journal of Cancer, 2020, 123 : 1535 - 1542
  • [44] Real-world outcomes among US Merkel cell carcinoma patients initiating immune checkpoint inhibitors or chemotherapy
    Chandra, Sunandana
    Zheng, Ying
    Pandya, Shivani
    Yu, Ting
    Kearney, Mairead
    Wang, Li
    Kim, Ruth
    Phatak, Hemant
    FUTURE ONCOLOGY, 2020, 16 (31) : 2521 - 2536
  • [45] Applicability of the lung immune prognostic index (LIPI) in patients with metastatic solid tumors when treated with immune checkpoint inhibitors (ICI) in early clinical trials
    Varga, A.
    Bernard-Tessier, A.
    Auclin, E.
    Perez, L. Mezquita
    Baldini, C.
    Planchard, D.
    Marabelle, A.
    Hollebecque, A.
    Besse, B.
    Massard, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] Immune-induced pneumonia in patients with advanced solid tumors treated with immunotherapy: a real-world assessment
    Wang, Chuhan
    Zhu, Hong
    Huang, Haiwen
    Sun, Zongqiong
    Teng, Yue
    Li, Yonggang
    FUTURE ONCOLOGY, 2023, 19 (03) : 259 - 270
  • [47] Genomic correlates of response and resistance to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC) in a real-world setting.
    Pramod, Nikhil
    Makarov, Vladimir
    Dawsey, Scott
    Pavicic, Paul G.
    Patgunarajah, Ubenthira
    Nair, Monica
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Wee, Christopher Eing
    Nizam, Amanda
    Mian, Omar Y.
    Nguyen, Jane
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 670 - 670
  • [48] Real-world cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: a retrospective controlled cohort study
    Zhang, Chuan
    Chen, Zhulu
    Mo, Chunhua
    Gao, Diansha
    Zhu, Yuxi
    Qin, Shu
    Zuo, Zhong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (12): : 6074 - +
  • [49] The Prevalence and Patterns of Toxicity With Immune Checkpoint Inhibitors in Solid Tumors: A Real-World Experience From a Tertiary Care Center in Oman
    Salman, Bushra
    Alward, Nameer M.
    Al-Hashami, Zamzam
    Al-Sharqi, Hadil
    Al -Sayegh, Hasan
    Burney, Ikram A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [50] Real-World Efficacy and Safety of Off-Label Use of Immune Checkpoint Inhibitors (ICI) in Cancer: A Retrospective Cohort Study in Qatar
    Abaza, S.
    Nasser, S.
    Abuyounis, M.
    Nounou, A.
    Rasul, K.
    Hamad, A.
    Elazzazy, S.
    DRUG SAFETY, 2022, 45 (10) : 1300 - 1301
12345